Mayinglong Pharmaceutical Group Co., LTD. revenue reports
Mayinglong Pharmaceutical Group Co., LTD. financial reports, Mayinglong Pharmaceutical Group Co., LTD. annual revenue in 2024. When does Mayinglong Pharmaceutical Group Co., LTD. report revenue?
Mayinglong Pharmaceutical Group Co., LTD. total revenue, net income and dynamics of changes in yuan today
Net income Mayinglong Pharmaceutical Group Co., LTD. - 117 260 481 ¥. Information about net income is used from open sources. The dynamics of Mayinglong Pharmaceutical Group Co., LTD. net income rose by 27 718 847 ¥. The assessment of the dynamics of Mayinglong Pharmaceutical Group Co., LTD. net income was made in comparison with the previous report. Here are the main financial indicators of Mayinglong Pharmaceutical Group Co., LTD.. Graph of finance company Mayinglong Pharmaceutical Group Co., LTD.. Mayinglong Pharmaceutical Group Co., LTD. net income is shown in blue on the graph. Mayinglong Pharmaceutical Group Co., LTD. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
860 956 194 ¥
+41.15 % ↑
117 260 481 ¥
-11.733 % ↓
31/12/2020
1 056 234 696 ¥
+74.52 % ↑
89 541 634 ¥
+61.27 % ↑
30/09/2020
754 287 955 ¥
+16.46 % ↑
94 257 269 ¥
+23.43 % ↑
30/06/2020
645 898 457 ¥
-2.916 % ↓
125 886 528 ¥
+49.77 % ↑
30/09/2019
647 694 853 ¥
-
76 362 819 ¥
-
30/06/2019
665 299 170 ¥
-
84 055 373 ¥
-
31/03/2019
609 962 721 ¥
-
132 847 246 ¥
-
31/12/2018
605 234 427 ¥
-
55 521 950 ¥
-
Show:
to
Mayinglong Pharmaceutical Group Co., LTD. financial report charts
The dates of the latest financial statements of Mayinglong Pharmaceutical Group Co., LTD.: 31/12/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Mayinglong Pharmaceutical Group Co., LTD. is 31/03/2021. Gross profit Mayinglong Pharmaceutical Group Co., LTD. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Mayinglong Pharmaceutical Group Co., LTD. is 319 007 658 ¥
Mayinglong Pharmaceutical Group Co., LTD. quarterly report dates
Cost of revenue Mayinglong Pharmaceutical Group Co., LTD. is the total cost of producing and distributing of products and services of a company. Cost of revenue Mayinglong Pharmaceutical Group Co., LTD. is 541 948 536 ¥ Total revenue Mayinglong Pharmaceutical Group Co., LTD. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Mayinglong Pharmaceutical Group Co., LTD. is 860 956 194 ¥ Operating income Mayinglong Pharmaceutical Group Co., LTD. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Mayinglong Pharmaceutical Group Co., LTD. is 130 024 973 ¥
Net income Mayinglong Pharmaceutical Group Co., LTD. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Mayinglong Pharmaceutical Group Co., LTD. is 117 260 481 ¥ Current assets Mayinglong Pharmaceutical Group Co., LTD. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Mayinglong Pharmaceutical Group Co., LTD. is 3 188 185 353 ¥ Total assets Mayinglong Pharmaceutical Group Co., LTD. refers to the total amount of assets owned by a person or entity. Total assets Mayinglong Pharmaceutical Group Co., LTD. is 4 000 994 175 ¥
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
319 007 658 ¥
341 241 513 ¥
315 368 322 ¥
309 290 325 ¥
260 993 506 ¥
286 537 477 ¥
267 309 803 ¥
285 363 526 ¥
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
541 948 536 ¥
714 993 183 ¥
438 919 633 ¥
336 608 132 ¥
386 701 347 ¥
378 761 693 ¥
342 652 918 ¥
319 870 901 ¥
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
860 956 194 ¥
1 056 234 696 ¥
754 287 955 ¥
645 898 457 ¥
647 694 853 ¥
665 299 170 ¥
609 962 721 ¥
605 234 427 ¥
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
647 694 853 ¥
665 299 170 ¥
609 962 721 ¥
605 234 427 ¥
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
130 024 973 ¥
56 842 448 ¥
91 857 698 ¥
113 713 156 ¥
66 555 788 ¥
103 772 016 ¥
124 736 492 ¥
62 474 349 ¥
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
117 260 481 ¥
89 541 634 ¥
94 257 269 ¥
125 886 528 ¥
76 362 819 ¥
84 055 373 ¥
132 847 246 ¥
55 521 950 ¥
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
14 730 343 ¥
20 470 257 ¥
13 011 943 ¥
12 086 360 ¥
10 014 805 ¥
14 647 769 ¥
12 215 337 ¥
8 088 299 ¥
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
730 931 221 ¥
999 392 248 ¥
662 430 257 ¥
532 185 301 ¥
581 139 065 ¥
561 527 154 ¥
485 226 229 ¥
542 760 078 ¥
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
3 188 185 353 ¥
3 111 313 328 ¥
3 134 528 762 ¥
2 932 312 580 ¥
2 637 664 928 ¥
2 527 788 086 ¥
2 386 686 295 ¥
2 266 616 124 ¥
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
4 000 994 175 ¥
3 866 460 220 ¥
3 809 766 282 ¥
3 546 974 148 ¥
3 308 704 713 ¥
3 192 671 958 ¥
3 042 097 280 ¥
2 926 538 082 ¥
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
1 252 846 285 ¥
2 073 001 542 ¥
1 575 671 159 ¥
1 563 649 124 ¥
899 283 907 ¥
1 376 066 520 ¥
1 154 029 173 ¥
1 106 071 003 ¥
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
613 680 422 ¥
567 954 268 ¥
442 765 029 ¥
462 476 869 ¥
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
729 999 056 ¥
685 067 627 ¥
554 865 561 ¥
574 674 277 ¥
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
22.06 %
21.46 %
18.24 %
19.64 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
2 959 172 636 ¥
2 849 405 053 ¥
2 766 279 928 ¥
2 673 689 539 ¥
2 495 121 939 ¥
2 429 481 227 ¥
2 408 849 943 ¥
2 270 737 339 ¥
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
93 814 977 ¥
9 684 891 ¥
28 802 787 ¥
100 898 379 ¥
Last revenue report of Mayinglong Pharmaceutical Group Co., LTD. was 31/03/2021. According to last financial report total revenue in Mayinglong Pharmaceutical Group Co., LTD. was 860 956 194 yuan and changed by +41.15% since last year. Net income in Mayinglong Pharmaceutical Group Co., LTD. was 117 260 481 ¥ in last quartal, net income changes to -11.733%.
Current cash Mayinglong Pharmaceutical Group Co., LTD. - the sum of all of the cash a company has on the date of report. Current cash Mayinglong Pharmaceutical Group Co., LTD. is 1 252 846 285 ¥
Mayinglong Pharmaceutical Group Co., LTD. stocks data
